Table 2.
Days post-antibody labeling for each antibody and cell type combination when the primary antibody is diminished to 90, 80, and 70% of the starting fluorescence levels in the live proliferative condition.
| Days post-labeling | CD44 ASCs | CD44 WI-38 s | CD90 ASCs | CD90 WI-38 s | CD105 ASCs | CD105 WI-38 s |
|---|---|---|---|---|---|---|
| Live Cell Ab > 90% Gone | 4 | 5 | 4 | 1 | 2 | 3 |
| Live Cell Ab > 80% Gone | 3 | 4 | 2 | 1 | 2 | 1 |
| Live Cell Ab > 70% Gone | 2 | 3 | 1 | 1 | 2 | 1 |